Tandem Diabetes Care (TNDM) Restructuring Costs (2025)
Tandem Diabetes Care (TNDM) posted Restructuring Costs of $20.0 million for Q2 2025.
Tandem Diabetes Care (TNDM) Restructuring Costs (2025) Analysis & Trends
Tandem Diabetes Care's Restructuring Costs history runs 1 years deep, the most recent figure standing at $20.0 million for Q2 2025.
- Quarterly Restructuring Costs changed N/A year-over-year to $20.0 million in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $20.0 million (changed N/A YoY) and the FY2025 annual result came in at $20.0 million, changed N/A from the prior year.
- Restructuring Costs was $20.0 million for Q2 2025 at Tandem Diabetes Care.
- Across five years, Restructuring Costs topped out at $20.0 million in Q2 2025 and bottomed at $20.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 19.95 Mn |